aTyr Pharma (LIFE) Tops Q1 EPS by 1c

aTyr Pharma (NASDAQ: LIFE) reported Q1 EPS of ($0.23), $0.01 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $240 thousand versus the consensus estimate of $27.5 thousand.

For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Home Depot beats estimates, reaffirms fiscal 2026 guidance
• Halozyme adds biotech executive Appelhans to its board